1. O’Neill J. Review on Antimicrobial Resistance. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations. December 2014. http://amr-review.org/
2. Стратегия предупреждения распространения антимикробной резистентности в Российской Федерации на период до 2030 года. Утверждена распоряжением Правительства Российской Федерации от 25 сентября 2017 г. №2045-р. / Strategiia preduprezhdeniia rasprostraneniia antimikrobnoi rezistentnosti v Rossiiskoi Federatsii na period do 2030 goda. Utverzhdena rasporiazheniem Pravitel'stva Rossiiskoi Federatsii ot 25 sentiabria 2017 g. №2045-r. [in Russian]
3. World Health Organization. Pneumococcal conjugate vaccine for childhood immunization – WHO position paper. Wееkly Epidemiol Rec 2007; 82: 93–104.
4. Позиция ВОЗ по полисахаридной пневмококковой вакцине. Еженедельный эпидемиол. бюл. 2008; 83 (42): 373–84. / Pozitsiia VOZ po polisakharidnoi pnevmokokkovoi vaktsine. Ezhenedel'nyi epidemiol. biul. 2008; 83 (42): 373–84. [in Russian]
5. Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека. Форма 6. 2017. / Federal'naia sluzhba po nadzoru v sfere zashchity prav potrebitelei i blagopoluchiia cheloveka. Forma 6. 2017. [in Russian]
6. Richter SS, Diekema DJ, Heilmann KP et al. Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States. Antimicrob Agents Chemother 2014; 58 (11): 6484–9. DOI: 10.1128/AAC.03344-14
7. Janoir C, Lepoutre A, Gutmann L, Varon E. Insight into resistance phenotypes of emergent non 13-valent pneumococcal conjugate vaccine type pneumococci isolated from invasive disease after 13-valent pneumococcal conjugate vaccine implementation in France. Open Forum Infect Dis 2016; 3 (1): ofw020. DOI: 10.1093/ofid/ofw020
8. Баранов А.А., Намазова Л.С., Таточенко В.К. Пневмококковая инфекция и связанные с ней заболевания – серьезная проблема современного здравоохранения. Педиатрическая фармакология. 2008; 5 (1): 7–12. / Baranov A.A., Namazova L.S., Tatochenko V.K. Pnevmokokkovaia infektsiia i sviazannye s nei zabolevaniia – ser'eznaia problema sovremennogo zdravookhraneniia. Pediatricheskaia farmakologiia. 2008; 5 (1): 7–12. [in Russian]
9. Jenkins SG, Brown SD, Farrell DJ. Trends in antimicrobial resistance among Streptococcus pneumonia isolated in the USA: update from PROTEKT US Years 1–4. Ann Clin Microbiol Antimicrob 2008; 11: 7–11.
10. Perez Trallero E, Martin Yerrero JE, Mazon A et al. Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996–1997 to 2006–2007). Antimicrob Agents Chemother 2008; 54: 2953–9.
11. Inoue M, Farrell DJ, Kaneko K et al. Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1–5 (1999–2004). Microb Drug Resist 2008; 14: 109–17.
12. Калиногорская О.С., Беланов С.С., Волкова М.О. и др. Антибиотикорезистентность и серотиповый состав Streptococcus pneumoniae, выделенных у детей в Санкт-Петербурге в 2010–2013 гг. Антибиотики и химиотерапия. 2015; 60 (1–2): 10–8. / Kalinogorskaia O.S., Belanov S.S., Volkova M.O. i dr. Antibiotikorezistentnost' i serotipovyi sostav Streptococcus pneumoniae, vydelennykh u detei v Sankt-Peterburge v 2010–2013 gg. Antibiotiki i khimioterapiia. 2015; 60 (1–2): 10–8. [in Russian]
13. Маянский Н.А., Алябьева Н.М., Пономаренко О.А. и др. Динамика распространенности серотипов и антибиотикорезистентности носоглоточных пневмококков, выделенных у детей в 2010–2016 гг.: результаты ретроспективного когортного исследования. Вопр. соврем. педиатрии. 2017; 16 (5): 413–23. DOI: 10.15690/vsp.v16i5.1806 / Maianskii N.A., Aliab'eva N.M., Ponomarenko O.A. i dr. Dinamika rasprostranennosti serotipov i antibiotikorezistentnosti nosoglotochnykh pnevmokokkov, vydelennykh u detei v 2010–2016 gg.: rezul'taty retrospektivnogo kogortnogo issledovaniia. Vopr. sovrem. pediatrii. 2017; 16 (5): 413–23. DOI: 10.15690/vsp.v16i5.1806 [in Russian]
14. Biedenbach DJ, Badal RE, Huang M-Y et al. In Vitro Activity of Oral Antimicrobial Agents against Pathogens Associated with Community-Acquired Upper Respiratory Tract and Urinary Tract Infections: A Five Country Surveillance Study. Infect Dis Ther 2016; 5: 139–53.
15. Torumkuney D, Mayanskiy N, Edelstein M et al. Results from the Survey of Antibiotic Resistance (SOAR) 2014–16 in Russia. J Antimicrob Chemother 2018; 73 (Suppl. 5): v14–v21.
16. Wang H, Chen M, Xu Y et. al. Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia: report from the community-acquired respiratory tract infection pathogen surveillance (CARTIPS) study, 2009–2010. Intern J Antimicrob Agents 2011; 38 (5): 376–83.
17. Qin L, Zhou Z, Hu B et al. Antimicrobial susceptibility and genetic characteristics of Haemophilus influenzae isolated from community aquires respiratory tract infection patients in Shanghai city, China. J Antimicrob Agents 2012; 18 (4): 508–14.
18. Bae SM, Lee JH, Lee SK et al. High prevalence of nasal carriage of b-lactamase-negative ampicillin resistant Haemophilus influenzae in healthy children in Korea. Epidemiol Infect 2012; 30: 1–9.
19. Yamaguch K, Ohno A, Ishii Y et al. In vitro susceptibilities to levofloxacin and various antibacterial agents of 12866 clinical isolates obtained from 72 centers in 2010. Jpn J Antibiot 2012; 65 (3): 181–206.
20. Todose C, Bumbacea D, Bogdan M, Grupului BACTRO. Antibiotic resistance of S. pneumoniae and H. influenza strains isolated from patients with community acquired respiratory tract infections. BACTRO multicenter, multidisciplinary study. Pneumologia 2011; 60 (1): 30–5.
21. Setchanova LP, Kostyanev T, Markovska R et al. Serotypes, antimicrobial susceptibility and beta-lactam resistance mechanisms of clinical Heamophilus influenzae isolates from Bulgaria in a prevaccinations period. Scand J Infect Dis 2012; 19: 24–9.
22. Dabernat H, Delmas C. Epidemiology and evolution of antibiotic resistance of Heamophilus influenzae in children 5 years of age or less in France, 2001–2008: a retrospective database analysis. Eur J Clin Microb Infect Dis 2012; 31 (10): 2745–53.
23. Стратегия и тактика рационального применения антимикробных средств в амбулаторной практике. Российские практические рекомендации. Под ред. С.В.Яковлева, С.В.Сидоренко, В.В.Рафальского, Т.В.Спичак. М.: Престо, 2014. / Strategiia i taktika ratsional'nogo primeneniia antimikrobnykh sredstv v ambulatornoi praktike. Rossiiskie prakticheskie rekomendatsii. Pod red. S.V.Iakovleva, S.V.Sidorenko, V.V.Rafal'skogo, T.V.Spichak. M.: Presto, 2014. [in Russian]
24. Боронина Л.Г., Саматова Е.В., Блинова С.М. Динамика антибиотикорезистентности у Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, вызывающих ЛОР-патологию и внебольничные бронхолегочные заболевания у детей на Среднем Урале. Клин. микробиология и антимикробная химиотерапия. 2017; 19 (2): 168–75. / Boronina L.G., Samatova E.V., Blinova S.M. Dinamika antibiotikorezistentnosti u Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, vyzyvaiushchikh LOR-patologiiu i vnebol'nichnye bronkholegochnye zabolevaniia u detei na Srednem Urale. Klin. mikrobiologiia i antimikrobnaia khimioterapiia. 2017; 19 (2): 168–75. [in Russian]
25. Сивая О.В., Козлов Р.С., Кречикова О.И. и др. и группа исследователей проекта ПеГАС. Антибиотикорезистентность Haemophilus influenzae в России: результаты многоцентрового проспективного исследования ПеГАС. Клин. микробиология и антимикробная химиотерапия. 2014; 16 (1): 57–9. / Sivaia O.V., Kozlov R.S., Krechikova O.I. i dr. i gruppa issledovatelei proekta PeGAS. Antibiotikorezistentnost' Haemophilus influenzae v Rossii: rezul'taty mnogotsentrovogo prospektivnogo issledovaniia PeGAS. Klin. mikrobiologiia i antimikrobnaia khimioterapiia. 2014; 16 (1): 57–9. [in Russian]
26. Катосова Л.К., Лазарева А.В., Хохлова Т.А. и др. Распространение и механизмы устойчивости к макролидам Streptococcus pyogenes, выделенных у детей. Антибиотики и химиотерапия. 2016; 61 (3–4): 23–9. / Katosova L.K., Lazareva A.V., Khokhlova T.A. i dr. Rasprostranenie i mekhanizmy ustoichivosti k makrolidam Streptococcus pyogenes, vydelennykh u detei. Antibiotiki i khimioterapiia. 2016; 61 (3–4): 23–9. [in Russian]
27. Рачина С.А., Козлов Р.С., Таточенко В.К., исследовательская группа ПАТРИОТ. Практика лечения острых респираторных инфекций у детей в амбулаторно-поликлинических учреждениях РФ: результаты многоцентрового фармако-эпидемиологического исследования. Клин. фармакология и терапия. 2016; 25 (2): 20–7. / Rachina S.A., Kozlov R.S., Tatochenko V.K., issledovatel'skaia gruppa PATRIOT. Praktika lecheniia ostrykh respiratornykh infektsii u detei v ambulatorno-poliklinicheskikh uchrezhdeniiakh RF: rezul'taty mnogotsentrovogo farmakoepidemiologicheskogo issledovaniia. Klin. farmakologiia i terapiia. 2016; 25 (2): 20–7. [in Russian]
28. WHO Model List of Essential Medicines for Children [Internet]. 6th List [updated 2017 March; cited 2017 Oct 9]. http://www.who.int/medicines/publications/essentialmedicines/6th_EMLc2017.pdf
29. Внебольничная пневмония у детей. Клинические рекомендации. Российское респираторное общество. Межрегиональное педиатрическое респираторное общество. Федерация педиатров стран СНГ. Московское общество детских врачей. 2015. / Vnebol'nichnaia pnevmoniia u detei. Klinicheskie rekomendatsii. Rossiiskoe respiratornoe obshchestvo. Mezhregional'noe pediatricheskoe respiratornoe obshchestvo. Federatsiia pediatrov stran SNG. Moskovskoe obshchestvo detskikh vrachei. 2015. [in Russian]
30. Клинические рекомендации. Отит средний острый. Министерство здравоохранения Российской Федерации. Национальная медицинская ассоциация оториноларингологов. 2016. / Klinicheskie rekomendatsii. Otit srednii ostryi. Ministerstvo zdravookhraneniia Rossiiskoi Federatsii. Natsional'naia meditsinskaia assotsiatsiia otorinolaringologov. 2016. [in Russian]
31. Клинические рекомендации. Острый синусит. Министерство здравоохранения Российской Федерации. Национальная медицинская ассоциация оториноларингологов. 2016. / Klinicheskie rekomendatsii. Ostryi sinusit. Ministerstvo zdravookhraneniia Rossiiskoi Federatsii. Natsional'naia meditsinskaia assotsiatsiia otorinolaringologov. 2016. [in Russian]
32. Клинические рекомендации. Острый тонзиллофарингит. Министерство здравоохранения Российской Федерации. Национальная медицинская ассоциация оториноларингологов. 2016. / Klinicheskie rekomendatsii. Ostryi tonzillofaringit. Ministerstvo zdravookhraneniia Rossiiskoi Federatsii. Natsional'naia meditsinskaia assotsiatsiia otorinolaringologov. 2016. [in Russian]
33. Бакрадзе М.Д., Таточенко В.К., Полякова А.С. и др. Низкая эффективность антибиотиков, назначаемых амбулаторно детям с пневмонией и острым средним отитом, как следствие несоблюдения клинических рекомендаций. Педиатрическая фармакология. 2016; 13 (5): 425–30. DOI: 10.15690/pf.v13i5.1636 / Bakradze M.D., Tatochenko V.K., Poliakova A.S. i dr. Nizkaia effektivnost' antibiotikov, naznachaemykh ambulatorno detiam s pnevmoniei i ostrym srednim otitom, kak sledstvie nesobliudeniia klinicheskikh rekomendatsii. Pediatricheskaia farmakologiia. 2016; 13 (5): 425–30. DOI: 10.15690/pf.v13i5.1636 [in Russian]
34. Ferri M, Ranucci E, Romagnoli P et al. Antimicrobial resistance: A global emerging threat to public health systems. Crit Rev Food Sci Nutr 2015. [Epub ahead of print].
35. Huttner A, Harbarth S, Carlet J et al. Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum. Antimicrob Resist Infect Control 2013; 2: 31.
36. Versalovic J. Manual of Clinical Microbiology. 10th edition. Vol. 1, 2. Washington: ASMPRESS, 2011.
37. Катосова Л.К., Пономаренко О.А., Хохлова Т.А. и др. Рост резистентности к макролидам Streptococcus pyogenes и определяющие ее молекулярные механизмы. Клин. микробиология и антимикробная химиотрапия. 2015; 17 (Прил. 1): 30. / Katosova L.K., Ponomarenko O.A., Khokhlova T.A. i dr. Rost rezistentnosti k makrolidam Streptococcus pyogenes i opredeliaiushchie ee molekuliarnye mekhanizmy. Klin. mikrobiologiia i antimikrobnaia khimiotrapiia. 2015; 17 (Pril. 1): 30. [in Russian]
38. Эмпирическая антибактериальная терапия инфекций дыхательных путей с учетом факторов риска резистентной флоры. Резолюция совета экспертов. Справочник поликлинического врача. 2018; 1: 28–32. / Resolution of the Expert Council "Empirical antibacterial therapy of respiratory infections and the risk factors of resistant flora". Handbook for Practitioners Doctors. 2018; 1: 28–32. [in Russian]

________________________________________________

1. O’Neill J. Review on Antimicrobial Resistance. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations. December 2014. http://amr-review.org/
2. Strategiia preduprezhdeniia rasprostraneniia antimikrobnoi rezistentnosti v Rossiiskoi Federatsii na period do 2030 goda. Utverzhdena rasporiazheniem Pravitel'stva Rossiiskoi Federatsii ot 25 sentiabria 2017 g. №2045-r. [in Russian]
3. World Health Organization. Pneumococcal conjugate vaccine for childhood immunization – WHO position paper. Wееkly Epidemiol Rec 2007; 82: 93–104.
4. Pozitsiia VOZ po polisakharidnoi pnevmokokkovoi vaktsine. Ezhenedel'nyi epidemiol. biul. 2008; 83 (42): 373–84. [in Russian]
5. Federal'naia sluzhba po nadzoru v sfere zashchity prav potrebitelei i blagopoluchiia cheloveka. Forma 6. 2017. [in Russian]
6. Richter SS, Diekema DJ, Heilmann KP et al. Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States. Antimicrob Agents Chemother 2014; 58 (11): 6484–9. DOI: 10.1128/AAC.03344-14
7. Janoir C, Lepoutre A, Gutmann L, Varon E. Insight into resistance phenotypes of emergent non 13-valent pneumococcal conjugate vaccine type pneumococci isolated from invasive disease after 13-valent pneumococcal conjugate vaccine implementation in France. Open Forum Infect Dis 2016; 3 (1): ofw020. DOI: 10.1093/ofid/ofw020
8. Baranov A.A., Namazova L.S., Tatochenko V.K. Pnevmokokkovaia infektsiia i sviazannye s nei zabolevaniia – ser'eznaia problema sovremennogo zdravookhraneniia. Pediatricheskaia farmakologiia. 2008; 5 (1): 7–12. [in Russian]
9. Jenkins SG, Brown SD, Farrell DJ. Trends in antimicrobial resistance among Streptococcus pneumonia isolated in the USA: update from PROTEKT US Years 1–4. Ann Clin Microbiol Antimicrob 2008; 11: 7–11.
10. Perez Trallero E, Martin Yerrero JE, Mazon A et al. Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996–1997 to 2006–2007). Antimicrob Agents Chemother 2008; 54: 2953–9.
11. Inoue M, Farrell DJ, Kaneko K et al. Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1–5 (1999–2004). Microb Drug Resist 2008; 14: 109–17.
12. Kalinogorskaia O.S., Belanov S.S., Volkova M.O. i dr. Antibiotikorezistentnost' i serotipovyi sostav Streptococcus pneumoniae, vydelennykh u detei v Sankt-Peterburge v 2010–2013 gg. Antibiotiki i khimioterapiia. 2015; 60 (1–2): 10–8. [in Russian]
13. Maianskii N.A., Aliab'eva N.M., Ponomarenko O.A. i dr. Dinamika rasprostranennosti serotipov i antibiotikorezistentnosti nosoglotochnykh pnevmokokkov, vydelennykh u detei v 2010–2016 gg.: rezul'taty retrospektivnogo kogortnogo issledovaniia. Vopr. sovrem. pediatrii. 2017; 16 (5): 413–23. DOI: 10.15690/vsp.v16i5.1806 [in Russian]
14. Biedenbach DJ, Badal RE, Huang M-Y et al. In Vitro Activity of Oral Antimicrobial Agents against Pathogens Associated with Community-Acquired Upper Respiratory Tract and Urinary Tract Infections: A Five Country Surveillance Study. Infect Dis Ther 2016; 5: 139–53.
15. Torumkuney D, Mayanskiy N, Edelstein M et al. Results from the Survey of Antibiotic Resistance (SOAR) 2014–16 in Russia. J Antimicrob Chemother 2018; 73 (Suppl. 5): v14–v21.
16. Wang H, Chen M, Xu Y et. al. Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia: report from the community-acquired respiratory tract infection pathogen surveillance (CARTIPS) study, 2009–2010. Intern J Antimicrob Agents 2011; 38 (5): 376–83.
17. Qin L, Zhou Z, Hu B et al. Antimicrobial susceptibility and genetic characteristics of Haemophilus influenzae isolated from community aquires respiratory tract infection patients in Shanghai city, China. J Antimicrob Agents 2012; 18 (4): 508–14.
18. Bae SM, Lee JH, Lee SK et al. High prevalence of nasal carriage of b-lactamase-negative ampicillin resistant Haemophilus influenzae in healthy children in Korea. Epidemiol Infect 2012; 30: 1–9.
19. Yamaguch K, Ohno A, Ishii Y et al. In vitro susceptibilities to levofloxacin and various antibacterial agents of 12866 clinical isolates obtained from 72 centers in 2010. Jpn J Antibiot 2012; 65 (3): 181–206.
20. Todose C, Bumbacea D, Bogdan M, Grupului BACTRO. Antibiotic resistance of S. pneumoniae and H. influenza strains isolated from patients with community acquired respiratory tract infections. BACTRO multicenter, multidisciplinary study. Pneumologia 2011; 60 (1): 30–5.
21. Setchanova LP, Kostyanev T, Markovska R et al. Serotypes, antimicrobial susceptibility and beta-lactam resistance mechanisms of clinical Heamophilus influenzae isolates from Bulgaria in a prevaccinations period. Scand J Infect Dis 2012; 19: 24–9.
22. Dabernat H, Delmas C. Epidemiology and evolution of antibiotic resistance of Heamophilus influenzae in children 5 years of age or less in France, 2001–2008: a retrospective database analysis. Eur J Clin Microb Infect Dis 2012; 31 (10): 2745–53.
23. Strategiia i taktika ratsional'nogo primeneniia antimikrobnykh sredstv v ambulatornoi praktike. Rossiiskie prakticheskie rekomendatsii. Pod red. S.V.Iakovleva, S.V.Sidorenko, V.V.Rafal'skogo, T.V.Spichak. M.: Presto, 2014. [in Russian]
24. Boronina L.G., Samatova E.V., Blinova S.M. Dinamika antibiotikorezistentnosti u Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, vyzyvaiushchikh LOR-patologiiu i vnebol'nichnye bronkholegochnye zabolevaniia u detei na Srednem Urale. Klin. mikrobiologiia i antimikrobnaia khimioterapiia. 2017; 19 (2): 168–75. [in Russian]
25. Sivaia O.V., Kozlov R.S., Krechikova O.I. i dr. i gruppa issledovatelei proekta PeGAS. Antibiotikorezistentnost' Haemophilus influenzae v Rossii: rezul'taty mnogotsentrovogo prospektivnogo issledovaniia PeGAS. Klin. mikrobiologiia i antimikrobnaia khimioterapiia. 2014; 16 (1): 57–9. [in Russian]
26. Katosova L.K., Lazareva A.V., Khokhlova T.A. i dr. Rasprostranenie i mekhanizmy ustoichivosti k makrolidam Streptococcus pyogenes, vydelennykh u detei. Antibiotiki i khimioterapiia. 2016; 61 (3–4): 23–9. [in Russian]
27. Rachina S.A., Kozlov R.S., Tatochenko V.K., issledovatel'skaia gruppa PATRIOT. Praktika lecheniia ostrykh respiratornykh infektsii u detei v ambulatorno-poliklinicheskikh uchrezhdeniiakh RF: rezul'taty mnogotsentrovogo farmakoepidemiologicheskogo issledovaniia. Klin. farmakologiia i terapiia. 2016; 25 (2): 20–7. [in Russian]
28. WHO Model List of Essential Medicines for Children [Internet]. 6th List [updated 2017 March; cited 2017 Oct 9]. http://www.who.int/medicines/publications/essentialmedicines/6th_EMLc2017.pdf
29. Vnebol'nichnaia pnevmoniia u detei. Klinicheskie rekomendatsii. Rossiiskoe respiratornoe obshchestvo. Mezhregional'noe pediatricheskoe respiratornoe obshchestvo. Federatsiia pediatrov stran SNG. Moskovskoe obshchestvo detskikh vrachei. 2015. [in Russian]
30. Klinicheskie rekomendatsii. Otit srednii ostryi. Ministerstvo zdravookhraneniia Rossiiskoi Federatsii. Natsional'naia meditsinskaia assotsiatsiia otorinolaringologov. 2016. [in Russian]
31. Klinicheskie rekomendatsii. Ostryi sinusit. Ministerstvo zdravookhraneniia Rossiiskoi Federatsii. Natsional'naia meditsinskaia assotsiatsiia otorinolaringologov. 2016. [in Russian]
32. Klinicheskie rekomendatsii. Ostryi tonzillofaringit. Ministerstvo zdravookhraneniia Rossiiskoi Federatsii. Natsional'naia meditsinskaia assotsiatsiia otorinolaringologov. 2016. [in Russian]
33. Bakradze M.D., Tatochenko V.K., Poliakova A.S. i dr. Nizkaia effektivnost' antibiotikov, naznachaemykh ambulatorno detiam s pnevmoniei i ostrym srednim otitom, kak sledstvie nesobliudeniia klinicheskikh rekomendatsii. Pediatricheskaia farmakologiia. 2016; 13 (5): 425–30. DOI: 10.15690/pf.v13i5.1636 [in Russian]
34. Ferri M, Ranucci E, Romagnoli P et al. Antimicrobial resistance: A global emerging threat to public health systems. Crit Rev Food Sci Nutr 2015. [Epub ahead of print].
35. Huttner A, Harbarth S, Carlet J et al. Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum. Antimicrob Resist Infect Control 2013; 2: 31.
36. Versalovic J. Manual of Clinical Microbiology. 10th edition. Vol. 1, 2. Washington: ASMPRESS, 2011.
37. Katosova L.K., Ponomarenko O.A., Khokhlova T.A. i dr. Rost rezistentnosti k makrolidam Streptococcus pyogenes i opredeliaiushchie ee molekuliarnye mekhanizmy. Klin. mikrobiologiia i antimikrobnaia khimiotrapiia. 2015; 17 (Pril. 1): 30. [in Russian]
38.  Resolution of the Expert Council "Empirical antibacterial therapy of respiratory infections and the risk factors of resistant flora". Handbook for Practitioners Doctors. 2018; 1: 28–32. [in Russian]